IMNMImmunome Inc.

Nasdaq immunome.com


$ 24.67 $ -0.84 (-3.29 %)    

Thursday, 28-Mar-2024 15:59:59 EDT
QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 24.68
$ 25.70
$ 0.00 x 0
$ 24.68 x 200
$ 24.25 - $ 25.70
$ 4.44 - $ 30.96
1,258,056
na
489.74M
$ 1.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 immunome-q4-adj-eps-015-beats-028-estimate-sales-383m-beat-207m-estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 4...

 stocks-pause-as-traders-reassess-interest-rate-path-gold-makes-new-highs-bitcoin-rebounds-whats-driving-markets-thursday

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting so...

 worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

 immunome-selects-arrayjets-arrayplex-platform-for-use-in-its-discovery-of-targeted-cancer-therapies

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has be...

 biotech-stocks-surge-to-start-2024-charts-look-great-but-will-the-trend-continue

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of ...

 imunon-inc-announces-imnn-101-preclinical-data-in-sars-cov-2-published-in-peer-reviewed-journal-vaccine

Data Show Strong Immunogenicity and Protection with IMUNON's PlaCCine DNA-Based Vaccine ModalityLAWRENCEVILLE, N.J., Feb. 2...

Core News & Articles

– Immunome entered into a definitive asset purchase agreement with Ayala to acquire AL102 earlier this month –

 immunome-prices-public-offering-of-10m-common-stock-at-20share

The gross proceeds to Immunome from the offering, before deducting underwriting discounts and commissions and offering expenses...

 immunome-announces-proposed-200m-public-offering-of-common-stock

Immunome, Inc. ("Immunome") (NASDAQ:IMNM), a biotechnology company dedicated to developing first-in-class and best-in-c...

 wedbush-maintains-outperform-on-immunome-raises-price-target-to-19

Wedbush analyst David Nierengarten maintains Immunome (NASDAQ:IMNM) with a Outperform and raises the price target from $12 t...

Core News & Articles

Under the terms of the deal, Zentalis will receive an up-front payment of $35 million in cash and Immunome common stock. Zental...

Core News & Articles

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer th...

 wedbush-initiates-coverage-on-immunome-with-outperform-rating-announces-price-target-of-12

Wedbush analyst David Nierengarten initiates coverage on Immunome (NASDAQ:IMNM) with a Outperform rating and announces Price...

 immunome-q3-eps-036-up-from-075-yoy-sales-356m

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.36) per share. This is a 52 percent increase over losses of $(0.75) per...

 immunome-q2-eps-046-misses-016-estimate-sales-426m

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.16) by...

 nasdaq-moves-lower-acuity-brands-earnings-top-estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow trad...

 why-franklin-covey-shares-are-trading-higher-by-25-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the com...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION